Effects of bisaramil on coronary-occlusion-reperfusion injury and free-radical-induced reactions

Pharmacological Research

Volumn 33, Issue 6, 1996, Pages 327-336

  Paróczai, Margit ^a   Roth, Elizabeth ^b   Matos, Gábor ^b   Temes, Gyula ^b   Lantos, János ^b   Karpati, Egon ^a  

^a GEDEON RICHTER LTD   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Bisaramil; Lipid peroxidation; Myocardial ischaemia reperfusion

Indexed keywords

ANTIARRHYTHMIC AGENT; BISARAMIL; CATALASE; FREE RADICAL; GLUTATHIONE; GLUTATHIONE DISULFIDE; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; FEMALE; HEART ARRHYTHMIA; HEART INFARCTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE WALL; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY;

EID: 0030174993     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1996.0045     Document Type: Article

References (49)

1. 1. Goldberg S, Greenspon AJ, Urban PL, Muza B, Berger B, Walinsky P, Maroko PR. Reperfusion arrhythmia: A marker of restoration of antegrade flow during intracoronary thrombolysis for acute myocardial infarction. Am Heart J 1983; 105: 26-32.
2. 2. Davies SW, Ranjadayalan K, Wickens DG. Lipid-peroxidation associated with successful thrombolysis. Lancet 1990; 335: 741-3.
3. 3. Mueller HS. Reperfusion injury in acute myocardial infarction: Present status and controversy. Clin Cardiol 1990; 13: 239-41.
4. 4. Bache RJ. Can drugs really limit infarct size? In: Hearse DJ, Yellow DM, eds. Therapeutic approaches to myocardial infarct size limitation. New York: Raven Press, 1984: 185-208.
5. 5. Torr S, Drake-Holland AJ, Main M, Hynd J, Isted K, Noble MIM. Effects on infarct size of reperfusion and pretreatment with beta-blockade and Ca-antagonists. Basic Res Cardiol 1989; 84: 564-82.
6. 6. Campbell CA, Przyklenk K, Kloner RA. Infarct size reduction: A review of the clinical trials. J Clin Pharmacol 1986; 26: 317-29.
7. 7. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. CAST and beyond Implications of the Cardiac Arrhythmia Suppression Trial. Eur Heart J 1990; 11: 194-9.
8. 8. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta-blockade during and after myocardial infarction: An overview of the randomized trials. Progr Cardiovas Dis 1985; XXVII: 335-71.
9. 9. Gibson RS, Boden WE, Theroux P. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind randomised multicenter trial. N Engl J Med 1986; 315: 423-9.
10. 10. The Danish study groups on verapamil in myocardial infarction. Effect of verapamil on mortality and major events after acute myocardial infarction. Am J Cardiol 1990; 66: 779-85.
11. 11. Canim AJ, Julian D, Janse G. The European Myocardial infarct Amiodarone trial (EMIAT). Am J Cardiol 1993; 72: 95F-8F.
12. 12. Navarro-Lopez F, Cosin J, Marrugat J, Guindo J, Bayes de Luna A. Comparison of the effects of amiodarone versus metoprolol on the frequency of ventricular arrhythmias and on mortality after acute myocardial infarction. Am J Cardiol 1993; 72: 1243-8.
13. 13. Rotmensh HH, Belhassen B, Ferguson RK. Amiodarone - benefits and risks in perspective. Am Heart J 1982; 104: 1117-9.
14. 14. Rotmensh HH, Belhassen B, Swanson B. Steady state serum amiodarone concentrations: relationships with antiarrhythmic efficacy and toxicity. Ann Int Med 1984; 101: 462-9.
15. 15. Paróczai M, Kárpáti E, Solti F. The effects of bisaramil on experimental arrhythmias. Pharmacol Res 1990; 22: 463-80.
16. 16. Haruno A, Hashimoto K. Antiarrhythmic effects of bisaramil in canine models of ventricular arrhythmia. Eur J Pharmacol 1993; 233: 1-6.
17. 17. Paróczai M, Kárpáti E, Marko R, Kecskeméti V. Electrophysiological actions of a new antiarrhythmic drug, bisaramil, on isolated heart preparations. Pharmacol Res 1992; 25: 75-85.
18. 18. Sunami A, Sawanobori T, Adaniya H, Hiraoka M. Electrophysiological properties of a new antiarrhythmic agent, bisaramil on guinea pig, rabbit and canine cardiac preparations. Naunyn-Schmied Arch Pharmacol 1991; 344: 323-30.
19. 19. Pugsley MK, Saint DA. Tonic and use-dependent block of sodium currents in isolated cardiac myocytes by bisaramil. Br J Pharmacol 1995; 113: 1-6.
20. 20. Paróczai M, Kárpáti M. Investigations to characterize a new antiarrhythmic drug, bisaramil. Pharmacol Res 1991; 24: 149-62.
21. 21. Ohakawa HN, Okishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analyt Biochem 1979; 95: 351-8.
22. 22. Tietze F. Enzymic method for quantitative determination of total and oxidized glutathione: applications to mammalian blood and other tissues. Analyt Biochem 1969; 27: 502-22.
23. 23. Misra HP, Fridovich I. The role of superoxide anion in the antioxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972; 27: 3170-5.
24. 24. Guarnieri C, Melandori G, Caldarera I, Scheda M, Ligabue A, Guizzardi S, Branzi A. Reduced oxidative activity of circulating neutrophils in patients after myocardial infarction. Cell Biochem Funct 1990; 8: 157-69.
25. 25. Placer ZA, Cushman LL, Johnson BC. Estimation of product of lipid peroxidation (malondialdehyde) in biochemical systems. Analyt Biochem 1966; 16: 359-64.
26. 26. Sedlak J, Lindsay RJ. Estimation of total protein-bound and non-protein sulfhydryl groups in tissue with Ellman' s reagent. Analyt Biochem 1968; 25: 192-205.
27. 27. Tzivoni D, Keren A, Granot H, Gottlieb A, Benhorin J, Stern S. Ventricular fibrillation caused by myocardial reperfusion in Prinzmetal's angina. Am Heart J 1983; 105: 323-5.
28. 28. Robinson LA, Braimbridge MV, Hearse DJ. Creatinphosphate: An additive myocardial protective and antiarrhythmic agent in cardioplegia. J Thorac Cardiovasc Surg 1984; 87: 190-200.
29. 29. Goldberg S, Greenspon AJ, Urban PL, Muza B, Berger B, Walinsky P, Maroko PR. Reperfusion arrhythmia: A marker of restoration of antegrade flow during intracoronary thrombolysis for acute myocardial infarction. Am Heart J 1983; 105: 26-32.
30. 30. McCord JM. Free radicals and myocardial ischemia overview and outlook. Free Radic Biol Med 1988; 4: 9-14.
31. 31. Garlick PB, Davies MJ, Hearse DJ, Slater TF. Direct detection of free radicals in the perfused rat heart using electron spin resonance spectroscopy. Circ Res 1987; 61: 757-60.
32. 32. Manning A, Bernies M, Grome R. Reperfusion arrhythmias: A study for the role of xanthine oxidase derived free radicals in rat heart. J Mol Cell Cardiol 1988; 20: 35-40.
33. 33. Przyklenk K, Kloner RA. Superoxide dismutase plus catalase improve contractile function in the canine model of the 'stunned myocardium'. Circ Res 1986; 58: 148-56.
34. 34. Tosaki A, Szekeres L, Hearse DJ. Diltiazem and the reduction of reperfusion-induced arrhythmias in the rat: protection is secondary to modification of ischemic injury and heart rate. J Mol Cell Cardiol 1987; 19: 441-51.
35. 35. Bernier M, Hearse DJ, Manning AS. Reperfusion-induced arrhythmias and oxygen-derived free-radicals. Studied with anti-free radical interventions and a free radical generating system in the isolated perfused rat heart. Circ Res 1986; 58: 331-40.
36. 36. Das KC, Misra HP. Lidocaine: a hydroxyl radical scavenger and singlet oxygen quencher. Mol Cell Biochem 1992; 115: 179-85.
37. 37. Frolkis W, Frolkis RA, Dubur G Ya. Antioxidants as antiarrhythmic drugs. Cardiology 1987; 74: 124-32.
38. 38. Mak T, Weglicki WB. Protection by β-blocking agents against free radical-mediated sarcolemmal lipid peroxidation. Circ Res 1988; 63: 262-6.
39. 39. Hearse DJ, Tosaki A. Free radicals and reperfusion-induced arrhythmias: protection by spin trap agent PBN in the rat heart. Circ Res 1987; 60: 375-83.
40. 40. Röth E, Török B. Effect of the ultrashort acting β-blocker Breviblock on free radical-mediated injuries during the early reperfusion state. Basic Res Cardiol 1991; 86: 422-33.
41. 41. Röth E. Effects of Ca-antagonists, beta-blockers and antioxidant during reperfusion period. Bratisl Lek Listy 1991; 3: 195-200.
42. 42. Röth E, Török B, Kelemen D, Pollak Zs. Chronic coronary ligature and antioxidant treatment. J Mol Cell Cardiol 1987; 19 Suppl III: 81.
43. 43. Janssen M, Koster JF, Bos E, deJong JW. Malondialdehyde and glutathione production in isolated perfused human and rat hearts. Circ Res 1993; 73: 681-8.
44. 44. Mehta JL, Nicols WW, Mehta P. Neutrophils as potential participants in acute myocardial ischemia: relevance to reperfusion. JACC 1988; 11: 1309-16.
45. 45. Engler RL, Dahlgren MD, Peterson MA, Dobbs A, Schmid-Schönbein GW. Accumulation of polymorphonuclear leukocytes during 3 h experimental myocardial ischemia. Am J Physiol 1986; 251: H93-100.
46. 46. Romson JR, Hook BG, Kunkel SL, Abrams GD, Schork MA, Lucchesi BR. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 1983; 67: 1016-23.
47. 47. Simpson PF, Mitsos SE, Ventura A. Postacyclin protects ischemic reperfused myocardium in the dog by inhibition of neutrophil activation. Am Heart J 1987; 113: 129-37.
48. 48. Mullane KM, Read ?, Salmon JA, Moncada S. Role of leukocytes in acute myocardial infarction in anaesthetized dogs: relationship to myocardial salvage by antiinflammatory drugs. J Pharmacol Exp Ther 1984; 228: 510-22.
49. 49. Himori N, Ono H, Taira N. Simultaneous assessment of effects of coronary vasodilators on the coronary blood flow and the myocardial contractility by using the blood-perfused canine papillary muscle. Jpn J Pharmacol 1976; 26: 427-35.